Article Details
Retrieved on: 2022-07-31 18:33:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
After 144 weeks of treatment, 88% of 93 patients enrolled in the SIMPL'HIV study who were taking dolutegravir (Tivicay) plus emtricitabine (Emtriva) ...
Article found on: www.medpagetoday.com
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here